NasdaqGS - Nasdaq Real Time Price USD
Design Therapeutics, Inc. (DSGN)
3.9500
-0.0700
(-1.74%)
As of 2:23:22 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.33 | -0.34 | -1.33 | -1.23 |
| Low Estimate | -0.35 | -0.37 | -1.43 | -1.49 |
| High Estimate | -0.31 | -0.32 | -1.26 | -0.85 |
| Year Ago EPS | -0.21 | -0.23 | -0.88 | -1.33 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.24 | -0.27 | -0.28 |
| EPS Actual | -0.21 | -0.23 | -0.24 | -0.31 |
| Difference | 0.02 | 0.01 | 0.03 | -0.03 |
| Surprise % | 10.00% | 5.48% | 10.00% | -10.71% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.33 | -0.34 | -1.33 | -1.23 |
| 7 Days Ago | -0.3 | -0.31 | -1.21 | -1.12 |
| 30 Days Ago | -0.3 | -0.31 | -1.21 | -1.12 |
| 60 Days Ago | -0.28 | -0.29 | -1.21 | -1.14 |
| 90 Days Ago | -0.28 | -0.29 | -1.21 | -1.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | 2 | 2 | 2 | 3 |
| Down Last 30 Days | 2 | 2 | 2 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DSGN | -57.14% | -47.83% | -51.14% | 7.27% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 8/6/2024 |
| Upgrade | Piper Sandler: Neutral to Overweight | 5/7/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/20/2024 |
| Reiterates | Wedbush: Neutral to Neutral | 3/20/2024 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 11/14/2023 |
| Downgrade | Wedbush: Outperform to Neutral | 8/15/2023 |
Related Tickers
CGEM Cullinan Therapeutics, Inc.
8.96
+2.40%
IKNA Ikena Oncology, Inc.
1.3300
+3.91%
VOR Vor Biopharma Inc.
0.2201
-6.06%
GLUE Monte Rosa Therapeutics, Inc.
4.7600
+5.78%
IPHA Innate Pharma S.A.
2.1400
-0.82%
EWTX Edgewise Therapeutics, Inc.
14.97
+1.91%
HOWL Werewolf Therapeutics, Inc.
1.3550
+12.92%
FHTX Foghorn Therapeutics Inc.
4.3650
+4.68%
STTK Shattuck Labs, Inc.
1.0050
-3.83%
STOK Stoke Therapeutics, Inc.
10.61
+7.00%